Form 8-K

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of The Securities Act of 1934

Date of Report (Date of earliest event reported): October 4, 2005


                          MERIDIAN BIOSCIENCE, INC.                           
(Exact name of Registrant as specified in its Charter)


                      Ohio                                          0-14902                              31-0888197        
(State or Other Jurisdiction of
         Incorporation)
(Commission File Number)  (IRS Employer
Identification No.)


3471 River Hills Drive, Cincinnati, Ohio    45244   
(Address of Principal Executive Offices) (Zip Code)


Registrant's telephone number, including area code (513) 271-3700


                                                                                                             
(Former name or former address, if changed since last report.)



Item 1.01 – Entry Into a Material Definitive Agreement

        Effective October 4, 2005, the Registrant made changes to the salary of a named executive officer structure namely: Richard L. Eberly, Executive Vice President and President of Meridian Life Science, $245,000.

SIGNATUARES

     Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused the report to be signed on its behalf by the undersigned, hereunto duly authorized.





Date:  October 5, 2005
MERIDIAN BIOSCIENCE, INC.


BY: /s/ Melissa Lueke
——————————————
Melissa Lueke
Vice President and Chief Financial Officer
(Principal Accounting Officer)